Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keyur B Shah

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 25, 2022
Circulating microRNAs in cellular and antibody-mediated heart transplant rejectionPalak Shah, Sean Agbor-Enoh, Pramita Bagchi, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 12, 2022
Higher levels of allograft injury in black patients early after heart transplantationAmar Doshi, Keyur B Shah, Sean Agbor-Enoh, et al.
Circulation. Heart Failure|November 25, 2024
Redefining Cardiac Antibody-Mediated Rejection With Donor-Specific Antibodies and Graft DysfunctionJason F Goldberg, Xin Tian, Ann Bon, et al.
European Journal of Heart Failure|July 6, 2017
A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fractionCristina Tita, Edward M Gilbert, Adrian B Van Bakel, et al.
The New England Journal of Medicine|January 10, 2024
Efficacy and Safety of Acoramidis in Transthyretin Amyloid CardiomyopathyJulian D Gillmore, Daniel P Judge, Francesco Cappelli, et al.
Diabetes/Metabolism Research and Reviews|May 17, 2020
The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA-HF studySalvatore Carbone, Hayley E Billingsley, Justin M Canada, et al.
Journal of the American Heart Association|July 12, 2021
Caregiver Health-Related Quality of Life, Burden, and Patient Outcomes in Ambulatory Advanced Heart Failure: A Report From REVIVALNisha A Gilotra, Salpy V Pamboukian, Maria Mountis, et al.
Future Cardiology|December 12, 2025
A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathyJulian D Gillmore, Daniel P Judge, Francesco Cappelli, et al.
Journal of Cardiac Failure|December 7, 2019
Impact of Socioeconomic Factors on Patient Desire for Early LVAD Therapy Prior to Inotrope DependenceInna Tchoukina, Keyur B Shah, Jennifer T Thibodeau, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|August 24, 2024
Society for Cardiovascular Magnetic Resonance 2023 Cases of SCMR case seriesJason N Johnson, Cara Hoke, Anna Lisa Chamis, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 25, 2022
Circulating microRNAs in cellular and antibody-mediated heart transplant rejectionPalak Shah, Sean Agbor-Enoh, Pramita Bagchi, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 12, 2022
Higher levels of allograft injury in black patients early after heart transplantationAmar Doshi, Keyur B Shah, Sean Agbor-Enoh, et al.
Circulation. Heart Failure|November 25, 2024
Redefining Cardiac Antibody-Mediated Rejection With Donor-Specific Antibodies and Graft DysfunctionJason F Goldberg, Xin Tian, Ann Bon, et al.
European Journal of Heart Failure|July 6, 2017
A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fractionCristina Tita, Edward M Gilbert, Adrian B Van Bakel, et al.
The New England Journal of Medicine|January 10, 2024
Efficacy and Safety of Acoramidis in Transthyretin Amyloid CardiomyopathyJulian D Gillmore, Daniel P Judge, Francesco Cappelli, et al.
Diabetes/Metabolism Research and Reviews|May 17, 2020
The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA-HF studySalvatore Carbone, Hayley E Billingsley, Justin M Canada, et al.
Journal of the American Heart Association|July 12, 2021
Caregiver Health-Related Quality of Life, Burden, and Patient Outcomes in Ambulatory Advanced Heart Failure: A Report From REVIVALNisha A Gilotra, Salpy V Pamboukian, Maria Mountis, et al.
Future Cardiology|December 12, 2025
A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathyJulian D Gillmore, Daniel P Judge, Francesco Cappelli, et al.
Journal of Cardiac Failure|December 7, 2019
Impact of Socioeconomic Factors on Patient Desire for Early LVAD Therapy Prior to Inotrope DependenceInna Tchoukina, Keyur B Shah, Jennifer T Thibodeau, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|August 24, 2024
Society for Cardiovascular Magnetic Resonance 2023 Cases of SCMR case seriesJason N Johnson, Cara Hoke, Anna Lisa Chamis, et al.
Pageof 13